Clinical Trial Update: ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of ACT001 for diffuse intrinsic pontine glioma and H3K27-altered diffuse midline glioma, which is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Intrinsic Pontine Glioma
• Diffuse Midline Glioma H3 K27-altered

Drugs mentioned

• ACT001

Snippet

Sponsor: Nationwide Children's Hospital | Conditions: Diffuse Intrinsic Pontine Gliomas (DIPG), Progressive DIPG | Phase 2 | Status: RECRUITING